Summary & Overview
CPT 95939: Central Motor Evoked Potential Study, Upper and Lower Limbs
CPT code 95939 represents a central motor evoked potential (cMEP) study of the upper and lower limbs, used diagnostically for multiple sclerosis and as a prognostic tool for motor recovery after stroke. This neurophysiology diagnostic procedure is clinically important for care planning, prognosis, and specialized neurologic assessment, with implications for inpatient and outpatient neurology services nationwide. Key national payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, common modifiers and coding considerations, and payer coverage patterns. The publication summarizes benchmarks and reimbursement context where available, highlights policy updates that affect coding and payment, and explains how the procedure integrates into stroke and multiple sclerosis care pathways. The report is intended for billing managers, neurology clinicians, and policy analysts seeking a focused reference on coding, clinical application, and payer handling of CPT code 95939. Data not available in the input is identified where applicable.
Billing Code Overview
CPT code 95939 describes a central motor evoked potential (cMEP) study performed in the upper and lower limbs. The procedure is used for diagnosis of multiple sclerosis and as a prognostic indicator for motor recovery after stroke.
Service type: Neurophysiology diagnostic study
Typical site of service: Hospital inpatient or outpatient neurophysiology laboratory, ambulatory surgical center, or specialized neurology clinic
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 52-year-old with progressive unilateral weakness and sensory complaints referred to neurology for evaluation of suspected multiple sclerosis and to establish baseline corticospinal tract function. The provider performs a central motor evoked potential (cMEP) study of the upper and lower limbs to assess central motor pathway conduction, correlate with MRI and clinical findings, and help prognosticate motor recovery after recent ischemic stroke. The clinical workflow includes obtaining informed consent, review of prior imaging and neurologic exam, pretest screening for contraindications to transcranial magnetic stimulation or electrical stimulation (implanted devices, active seizure), positioning the patient supine or semi-recumbent, placing recording electrodes on selected limb muscles, delivering transcranial magnetic or electrical stimulation to motor cortex, recording motor responses from bilateral upper and lower limb muscles, measuring central motor conduction time (CMCT) and response amplitudes, documenting findings in the medical record, and communicating results to the referring clinician for diagnosis and prognosis. Typical site of service is an outpatient neurology clinic, hospital neurology department, or neurophysiology laboratory. The service type is diagnostic neurophysiology testing focused on central motor pathway assessment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation of the test separate from the technical component. |